Figure 6

Survival curves of PDAC patients. The 4-year overall survival rate was significantly poorer in the PDAC + OJ group than in the PDAC group (log rank p = 0.0191). PDAC pancreatic ductal adenocarcinoma, OJ obstructive jaundice.

Survival curves of PDAC patients. The 4-year overall survival rate was significantly poorer in the PDAC + OJ group than in the PDAC group (log rank p = 0.0191). PDAC pancreatic ductal adenocarcinoma, OJ obstructive jaundice.